Leerink Partners Starts AnaptysBio (ANAB) at Outperform
Tweet
Share
E-mailGet Alerts ANAB Hot Sheet
Price: $57.94 +3.43%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Partners analyst David Risinger initiates coverage on AnaptysBio (NASDAQ: ANAB) with a Outperform rating and a price target of $47.00.
For an analyst ratings summary and ratings history on AnaptysBio click here. For more ratings news on AnaptysBio click here.
Shares of AnaptysBio closed at $21.27 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Axis Capital Limited Assumes Jubilant Foodworks Ltd (JUBI:IN) at Reduce (3)
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
